Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicaPlant in Aneurysmal Subarachnoid Haemorrhage
NCT04269408Phase 2Completed
- Sponsor
- BIT Pharma
- Start
- Apr 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of nicardipine in aneurysmal subarachnoid hemorrhage (SAH), sponsored by BIT Pharma. Started Apr 2020; status: completed.
02
Drugs
nicardipine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04269408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04269408.